EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Multi-Omics Meets Premalignancy: Paving the Way for Early Prevention of Cancer

Feiran Zhang, Ziyi Zhou, Peng Zhang, Shao Li iD

Research · 2025-01 · 8

DOI: 10.34133/research.0930 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Research, online erschienen am 17.10.2025. Verfasst von Feiran Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute for TCM-X, MOE Key Laboratory of Bioinformatics, Bioinformatics Division, BNRist, Department of Automation, Tsinghua University, Beijing 10…. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 195 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Comprehensive understanding of premalignant lesions (PMLs) represents a pivotal opportunity for cancer early detection and interception. Recently, advances in multi-omics technologies and artificial intelligence (AI) methods have provided unprecedented insights into PML-induced tumorigenesis. In this paper, we firstly catalog clinically recognized PMLs across 15 cancer types, emphasizing their epidemiological profiles and malignant transformation potentials. Then, we summarize recent intriguing discoveries and remaining challenges from bulk, single-cell, and spatial omics studies, highlighting how these omics technologies reveal the dynamic molecular, cellular, and spatial evolution from precancerous states to invasive malignancies. We further discuss network-based computational strategies for multi-omics integration and tumorigenesis trajectory inference, with applications of recent deep learning-based AI approaches. Finally, we highlight translational implications for PMLs, including developing high-precision early-diagnosis biomarkers and targeted pharmacological preventive strategies. Collectively, this paper underscores how the convergence of high-resolution multi-omics with sophisticated AI is poised to redefine PML research, enabling pan-cancer exceedingly-early risk stratification and pharmacological prevention.

Autor:innen und Institutionen

  • Institute for TCM-X, MOE Key Laboratory of Bioinformatics, Bioinformatics Division, BNRist, Department of Automation, Tsinghua University, Beijing 100084, China.

ORCID-Profile: Shao Li

Förderung

  • National Natural Science Foundation of China
  • Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine

Zitieren

APA

Zhang, F., Zhou, Z., Zhang, P., & Li, S. (2025). Multi-Omics Meets Premalignancy: Paving the Way for Early Prevention of Cancer. Research, 8. https://doi.org/10.34133/research.0930

Vancouver

Zhang F, Zhou Z, Zhang P, Li S. Multi-Omics Meets Premalignancy: Paving the Way for Early Prevention of Cancer. Research. 2025;8. doi:10.34133/research.0930

BibTeX
@article{Zhang2025,
  author = {Zhang, Feiran and Zhou, Ziyi and Zhang, Peng and Li, Shao},
  title = {Multi-Omics Meets Premalignancy: Paving the Way for Early Prevention of Cancer},
  journal = {Research},
  year = {2025},
  volume = {8},
  doi = {10.34133/research.0930}
}
Kostenlos starten →